Vast Therapeutics

Vast Therapeutics, a subsidiary of KNOW Bio and formerly known as Novoclem Therapeutics, is dedicated to developing BIOC51, an inhaled nitric oxide therapy, to treat cystic fibrosis patients battling chronic Pseudomonas aeruginosa infections.